Sheel Biotech Limited (NSE:SHEEL)
India
· Delayed Price · Currency is INR 46.90
+1.90 (4.22%)
At close: Apr 28, 2026
Sheel Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Cash & Equivalents | 2.05 | 4.64 | 6.03 | 2.11 | 3.11 | 4.62 |
| Short-Term Investments | - | 16.06 | 12.27 | 12.59 | - | 41.33 |
| Cash & Short-Term Investments | 2.05 | 20.7 | 18.3 | 14.7 | 3.11 | 45.95 |
| Cash Growth | - | 13.12% | 24.46% | 372.66% | -93.23% | - |
| Accounts Receivable | 514.53 | 550.79 | 577.01 | 560.46 | 647.07 | 606.85 |
| Other Receivables | - | 0.26 | - | - | - | - |
| Receivables | 562.04 | 551.05 | 577.01 | 560.46 | 647.07 | 606.85 |
| Inventory | 420.5 | 393.85 | 327.74 | 193 | 118.28 | 62.75 |
| Prepaid Expenses | - | 0.78 | 0.29 | 0.46 | 0.75 | 0.49 |
| Other Current Assets | 124.07 | 44.54 | 30.66 | 59.36 | 30.75 | 23.64 |
| Total Current Assets | 1,109 | 1,011 | 954.01 | 827.97 | 799.96 | 739.68 |
| Property, Plant & Equipment | 69.95 | 74.74 | 72.21 | 79.11 | 77.64 | 75.46 |
| Long-Term Investments | 7.92 | 7.92 | 8.02 | 8.02 | 8.02 | 0.1 |
| Other Intangible Assets | 0.13 | 0.14 | 0.16 | 0.19 | 0.28 | - |
| Long-Term Deferred Tax Assets | 0.14 | 0.49 | 1.07 | - | - | - |
| Other Long-Term Assets | 52.21 | 38.62 | 24 | 23.66 | 46.73 | - |
| Total Assets | 1,239 | 1,133 | 1,059 | 938.94 | 932.63 | 823.44 |
| Accounts Payable | 37.79 | 41.41 | 45.86 | 82.03 | 83.4 | 34.06 |
| Accrued Expenses | 21.38 | 10.33 | 9.5 | 8.82 | 10.18 | 7.63 |
| Short-Term Debt | - | 123.43 | 130.12 | 78.59 | 91.53 | 87.56 |
| Current Portion of Long-Term Debt | 192.03 | 1.95 | 2.59 | 18.7 | 4.69 | 3.17 |
| Current Income Taxes Payable | - | 21.29 | 19.9 | 13.24 | - | - |
| Other Current Liabilities | 62.17 | 41.75 | 18.1 | 3.78 | 0 | 1.56 |
| Total Current Liabilities | 313.37 | 240.16 | 226.07 | 205.16 | 189.81 | 133.98 |
| Long-Term Debt | 78.56 | 48.23 | 102.68 | 94.41 | 139.61 | 121.21 |
| Pension & Post-Retirement Benefits | 6.46 | 5.9 | 3.81 | 2.91 | - | 0.72 |
| Long-Term Deferred Tax Liabilities | - | - | - | 1.05 | 0.36 | 0.4 |
| Total Liabilities | 398.4 | 294.28 | 332.56 | 303.53 | 329.77 | 256.31 |
| Common Stock | 149.53 | 149.53 | 41.44 | 41.44 | 41.44 | 41.44 |
| Additional Paid-In Capital | - | 19.74 | 4 | 4 | - | - |
| Retained Earnings | - | 669.28 | 681.47 | 589.98 | 561.42 | - |
| Comprehensive Income & Other | 691.09 | - | - | - | - | 525.69 |
| Shareholders' Equity | 840.61 | 838.54 | 726.9 | 635.42 | 602.86 | 567.13 |
| Total Liabilities & Equity | 1,239 | 1,133 | 1,059 | 938.94 | 932.63 | 823.44 |
| Total Debt | 270.59 | 173.61 | 235.4 | 191.71 | 235.83 | 211.94 |
| Net Cash (Debt) | -268.55 | -152.91 | -217.1 | -177.01 | -232.72 | -165.99 |
| Net Cash Per Share | -18.27 | -10.37 | -14.97 | -12.20 | -16.05 | -40.06 |
| Filing Date Shares Outstanding | 14.5 | 20.35 | 14.5 | 4.14 | 4.14 | 4.14 |
| Total Common Shares Outstanding | 14.5 | 14.95 | 14.5 | 4.14 | 4.14 | 4.14 |
| Working Capital | 795.29 | 770.76 | 727.93 | 622.81 | 610.15 | 605.71 |
| Book Value Per Share | 57.97 | 56.08 | 50.12 | 153.34 | 145.49 | 136.87 |
| Tangible Book Value | 840.49 | 838.4 | 726.74 | 635.23 | 602.58 | 567.13 |
| Tangible Book Value Per Share | 57.96 | 56.07 | 50.11 | 153.30 | 145.42 | 136.87 |
| Land | - | 20.76 | 20.76 | 20.76 | 20.76 | - |
| Buildings | - | 38.11 | 39.4 | 39.4 | 37.98 | - |
| Machinery | - | 152.44 | 140.06 | 137.12 | 116.18 | - |
| Construction In Progress | - | - | - | - | 1.41 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.